A detailed history of Td Asset Management Inc transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 187,788 shares of LBPH stock, worth $11.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
187,788
Previous 174,188 7.81%
Holding current value
$11.3 Million
Previous $4.71 Million 32.92%
% of portfolio
0.01%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$27.58 - $39.5 $375,088 - $537,200
13,600 Added 7.81%
187,788 $6.26 Million
Q2 2024

Aug 02, 2024

BUY
$17.0 - $27.03 $567,800 - $902,802
33,400 Added 23.72%
174,188 $4.71 Million
Q1 2024

May 08, 2024

BUY
$18.89 - $26.06 $883,409 - $1.22 Million
46,766 Added 49.74%
140,788 $3.04 Million
Q4 2023

Feb 12, 2024

SELL
$3.68 - $6.5 $100,832 - $178,100
-27,400 Reduced 22.57%
94,022 $566,000
Q3 2023

Oct 27, 2023

BUY
$5.49 - $7.49 $399,732 - $545,354
72,811 Added 149.78%
121,422 $675,000
Q2 2023

Aug 09, 2023

BUY
$4.19 - $10.05 $46,090 - $110,550
11,000 Added 29.25%
48,611 $356,000
Q2 2022

Aug 04, 2022

SELL
$2.96 - $5.38 $38 - $69
-13 Reduced 0.03%
37,611 $116,000
Q1 2022

May 10, 2022

SELL
$4.0 - $6.0 $52,904 - $79,356
-13,226 Reduced 26.01%
37,624 $195,000
Q4 2021

Feb 10, 2022

SELL
$4.75 - $9.45 $30,518 - $60,716
-6,425 Reduced 11.22%
50,850 $246,000
Q3 2021

Nov 09, 2021

BUY
$8.65 - $11.36 $348,439 - $457,603
40,282 Added 237.05%
57,275 $510,000
Q1 2021

May 14, 2021

BUY
$16.0 - $16.89 $271,888 - $287,011
16,993 New
16,993 $277,000

Others Institutions Holding LBPH

About Longboard Pharmaceuticals, Inc.


  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $815M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.